Pfizer Stock News

RIO DE JANEIRO, BRAZIL - Anvisa, Brazil''s regulatory body, authorized this Thursday for the first time the vaccination of children against Covid-19 with the immunizer from Pfizer/BioNTech. However, the Ministry of Health lacks specific doses intended for people between 5 and 11 years of age. The regulatory agency made a series of technical recommendations to [] The post Pfizer Covid vaccine authorized in Brazil for children between 5 and 11 years of age appeared first on The Rio Times .

A CDC panel recommended the Pfizer and Moderna COVID-19 vaccines be preferred over J&J''s due to the chance of rare but dangerous blood clots.

Intrua Financial LLC lifted its position in Pfizer Inc. (NYSE:PFE) by 55.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 37,054 shares of the biopharmaceutical companys stock after buying an additional 13,288 shares during the quarter. Intrua Financial LLCs holdings in Pfizer []

The Centers for Disease Control and Prevention is set to decide on recommending United States citizens to receive Pfizer or Moderna COVID-19 vaccines over the one developed by Johnson & Johnson.

DUBLIN--(BUSINESS WIRE)--The "Rare Disease Drug Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type" report has been added to ResearchAndMarkets.com''s offering. This report describes the global market size of Rare Disease Drug from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026. For the geography segment, regional supply, demand, major playe

The antiviral Covid-19 pill developed by Pfizer, called Paxlovid, has been given the green light to be used in emergencies by the European Medicines Agency (EMA) on Thursday. The medicine has not yet been authorised in the EU, but received a positive opinion and can be used to treat adults with Covid-19 who are at []

The European Union drug regulator has issued advice on the use of Pfizer’s experimental pill to treat COVID-19 for countries where authorities may want to use it before it is officially authorized amid surging infection rates

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued advice on the use of PAXLOVID (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), stating that PAXLOVID can be used to treat adults with COVID-19 who do not require supplemental oxygen and who are at increased risk of progressing to severe disease. The CHMP also recommend that PAXLOVID should be administered as s

The European Medicines Agency approved on Thursday the emergency use of Pfizer''s COVID-19 pill Paxlovid in the early stages of the disease to prevent severe cases. "The Agency''s advice c

SlateStone Wealth LLC raised its stake in Pfizer Inc. (NYSE:PFE) by 22.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,587 shares of the biopharmaceutical companys stock after acquiring an additional 1,412 shares during the period. SlateStone Wealth LLCs holdings in Pfizer were []

BOOSTER doses of COVID-19 vaccines are to be rolled to people in Spain aged between 40 and 59 years. The injections will follow six months after the second shots of the Moderna and Pfizer formulas were administered. People aged under 60 who received AstraZeneca shots will only have a three-month wait period to get the []

Key Takeaways - Studies find that two-dose courses of Pfizer vaccine are less effective against Omicron, while a booster provides significant protection. Russia vetoed a UN Security Council resolution that for the first time would have treated climate change as a threat to peace. JPMorgan raised its forecast for Q4 GDP for China. Analysis: Emerging and Existing Hotspots: Burkina Faso and the Crisis in the Sahel. Please see full Newsletter below for more information. By: Dentons

One of the largest hospital systems in Ohio is not distributing the FDAs fully approved COVID-vaccine. As of todays stock, we are currently distributing the Pfizer vaccine that does not have the Comirnaty branding label, a spokeswoman said, per the Ohio Star. In August, the FDA approved Pfizers vaccine called Comirnaty. However, OhioHealth a [] The post Ohios Largest Hospital System Still Distributing Unapproved Pfizer COVID-19 Vaccine appeared first on Human Events .

WALTHAM, Mass.--(BUSINESS WIRE)--Palleon Pharmaceuticals, a company pioneering the field of glyco-immunology to treat cancer and inflammatory diseases, today announced the appointment of Denis Patrick, Ph.D., to its Board of Directors. Dr. Patrick is Vice President and Head of Partnering Innovation at Pfizer and a Managing Partner at Pfizer Ventures, the venture capital arm of Pfizer Inc. Denis experience at multiple major biopharmaceutical companies and his knowledge of oncologic drug discov